Moderna, Inc. — Director's Dealing 2020

Sep 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-09-08

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-08	Common Stock	M	10000	$20.93	Acquired	10000	Direct
2020-09-08	Common Stock	M	1467	$12.21	Acquired	11467	Direct
2020-09-08	Common Stock	M	5000	$14.22	Acquired	16467	Direct
2020-09-08	Common Stock	M	10000	$19.15	Acquired	26467	Direct
2020-09-08	Common Stock	S	6395	$54.69	Disposed	20072	Direct
2020-09-08	Common Stock	S	8655	$55.88	Disposed	11417	Direct
2020-09-08	Common Stock	S	6457	$56.82	Disposed	4960	Direct
2020-09-08	Common Stock	S	4960	$57.88	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-08	Stock Option (Right to Buy)	$20.93	M	10000	Disposed	2029-03-08	Common Stock (10000)	Direct
2020-09-08	Stock Option (Right to Buy)	$12.21	M	1467	Disposed	2027-02-23	Common Stock (1467)	Direct
2020-09-08	Stock Option (Right to Buy)	$14.22	M	5000	Disposed	2028-02-28	Common Stock (5000)	Direct
2020-09-08	Stock Option (Right to Buy)	$19.15	M	10000	Disposed	2026-08-10	Common Stock (10000)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.30 to $55.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.36 to $56.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.37 to $57.31. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.39 to $58.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.

F7: 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.

F8: This option is fully vested and exercisable.